News
The renin-angiotensin-aldosterone system (RAAS) is a regulator of blood pressure and cardiovascular function, currently being researched due to COVID-19.
Kreutz R, Algharably EAE, Azizi M, et al. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
These patients are often prescribed renin–angiotensin–aldosterone system (RAAS) inhibitors, including angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). This ...
Unique Characteristics of Hypertension in Blacks That Influence BP Responses to Drugs That Block the Renin-Angiotensin Activating System (RAAS) The prevalence of hypertension (defined as a ...
Evaluated renin-angiotensin-aldosterone system (RAAS) inhibitor drugs and their maximum doses, listed in descending order of observed frequency at index: lisinopril, 40 mg; losartan, 100 mg ...
ACE inhibitors and angiotensin-receptor blockers have been found to effectively slow progression of kidney disease. It has been theorized that dual blockade of the renin-angiotensin-aldosterone ...
Researchers conducted an umbrella review and meta-analysis of the RAAS inhibitors' impact on COVID-19 clinical outcomes.
The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hypothesize that ACE2 may be beneficial ...
“ACE inhibitors and ARBs exert opposite effects on angiotensin II” Angiotensinogen is produced mainly in the liver and fat cells, in response to poor perfusion, and acts as a pro-signal in the complex ...
COMMENTARY Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results